Skip to content

Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital

Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital: the COPACNE Cohort.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03465150
Acronym
COPACNE
Enrollment
200
Registered
2018-03-14
Start date
2018-09-23
Completion date
2033-12-28
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Keywords

Acne, Cohort, prospective, risk factors

Brief summary

With 24 million results associated with Google's searchon keywords "severe acne", Pr Dreno's team understand better thatthis disease, which affects many French people, is a real concern of Public Health and not a "forced evil" of the adolescent period, which will eventually resolve itself. Acne does not affect the vital prognosis, but its psychosocial impact is major and should not be underestimated. Paradoxically, despite the high prevalence of acne, few quality epidemiological studies have been published. Physicians are often helpless when faced with patients' questions. They often need a lot of explanations, especially on the factors aggravating this dermatosis, which greatly affects their quality of life. This cohort, the first of its kind in France, will determine the predictive factors of therapeutic response, endogenous and environmental factors impacting on the severity of acne assess the quality of life and psychological impact of acne patients, determine the patient's course of care and the associated costs. Pr Dreno's team will also build up a bio collection (bacteriological samples).

Detailed description

All patients going for the first time in specialized consultation "acne" at Nantes University Hospital , and who meet the inclusion criteria will be included in the COPACNE cohort. Inclusion will take place at the first consultation, after information and agreement of the patient and, if applicable, his or her legal representatives. The frequency of each patient's follow-up visits will be determined on a case-by-case basis according to the patient's medical needs (generally, the interval between 2 visits is between 1 and 4 months).

Interventions

OTHERacne

Patient with acne

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patient with acne * Patient (or parents/guardians for minors) who are not opposed to participating in the cohort. * Subjects affiliated to an appropriate health insurance

Exclusion criteria

* Dermatosis of the face other than acne * Refusal to participate by the minor or parent/guardian * Adults under a legal protection regime (guardianship, trusteeship, judicial safeguard)

Design outcomes

Primary

MeasureTime frameDescription
Measure of Acne stage2 yearscomposite criteria. the scale is GEA for Global Evaluation Acne Scale with 0 no acne to 5 severe acne

Secondary

MeasureTime frameDescription
assessing patients' quality of life2 yearscomposite criteria. CADI score is calculated by summing the score of each question resulting in a possible maximum of 15 and a minimum of 0. The higher the score, the more the quality of life is impaired.
cost of acne illness2 yearsreimbursement data relating to hospitalizations and care in town recorded by the Health Insurance in the SNIIRAM database.
Bacteriological sample to find Propionibacterium acnes, Hormonal check-up on blood sample2 yearsCorrelation between bacterial and blood samples and the efficacity of the treatment

Countries

France

Contacts

CONTACTBrigitte DRENO
brigitte.dreno@wanadoo.fr0240083137
CONTACTAmir khammari
amir.khammari@chu-nantes.fr
PRINCIPAL_INVESTIGATORBrigitte DRENO, PU-PH

Nantes University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026